Your browser doesn't support javascript.
loading
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses.
Block, Violeta; Sevdali, Eirini; Recher, Mike; Abolhassani, Hassan; Hammarstrom, Lennart; Smulski, Cristian R; Baronio, Manuela; Plebani, Alessandro; Proietti, Michele; Speletas, Matthaios; Warnatz, Klaus; Voll, Reinhard E; Lougaris, Vassilios; Schneider, Pascal; Eibel, Hermann.
Afiliação
  • Block V; Department of Rheumatology and Clinical Immunology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Sevdali E; Center for Chronic Immunodeficiency, Medial Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Recher M; Department of Rheumatology and Clinical Immunology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Abolhassani H; Center for Chronic Immunodeficiency, Medial Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Hammarstrom L; Immunodeficiency Clinic and Laboratory, Medical Outpatient Unit and Department Biomedicine, University Hospital and University of Basel, Basel, Switzerland.
  • Smulski CR; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
  • Baronio M; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Plebani A; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
  • Proietti M; Department of Rheumatology and Clinical Immunology, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Speletas M; Medical Physics Department, Centro Atómico Bariloche, Comisión Nacional de Energía Atómica (CNEA), Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET), San Carlos de Bariloche, Río Negro, Argentina.
  • Warnatz K; Department of Clinical and Exp. Sciences, University of Brescia, Brescia, Italy.
  • Voll RE; Department of Clinical and Exp. Sciences, University of Brescia, Brescia, Italy.
  • Lougaris V; Center for Chronic Immunodeficiency, Medial Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schneider P; Institute for Immunodeficiency, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Eibel H; Department of Immunology & Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece.
J Clin Immunol ; 43(2): 391-405, 2023 02.
Article em En | MEDLINE | ID: mdl-36308663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunodeficiência de Variável Comum / Receptor do Fator Ativador de Células B Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunodeficiência de Variável Comum / Receptor do Fator Ativador de Células B Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article